HIGHLIGHTS
- who: Gerie J. Glas and collaborators from the Laboratory of Experimental Intensive Care and Anesthesiology (Lu00b7Eu00b7Iu00b7Cu00b7A), Amsterdam University Medical , AZ Amsterdam, The Netherlands have published the Article: Clinical Medicine, in the Journal: (JOURNAL)
- what: The authors aimed to investigate the safety feasibility and effectiveness of nebulized heparin. Study medication could be temporarily discontinued for the following reasons: suspected HIT, surgical procedures, clinically relevant bleedings, APTT > 150 s, platelet count u2264 10 u00d7 109 /L, excessive blood in lavage fluids, or sputum. One patient received two out of 72 scheduled heparin nebulizations as the study was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.